Genmab to Submit Biologics License Application to U.S. Food and Drug Administration for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL)
Company Announcement COPENHAGEN, Denmark; June 30, 2022 – Genmab A/S (Nasdaq: GMAB) today announced its…
AI Turns Vulnerability Management Into a Throughput Problem
Neutrik® Connects Made-To-Order, High-Performance AV Solutions For RCI Custom
AceDraft Announces AceDraft, a Free ATS Resume Tool to Help Gen Z Job Seekers Match Job Descriptions
uSMART Becomes the World’s First Technology Brokerage to Offer Both ‘Night and Pre-Market Trading’ in U.S. Options
Chervon Names Doug Palmer Vice President of Finance – Canada